Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats
Simvastatin is an established anti-hyperlipidemic drug and few studies have indicated its role in the mitigation of oxidative stress. However, a systematic study considering molecular binding/interaction of simvastatin with anti-oxidant enzymes followed by confirmational in vitro and in vivo studies...
Saved in:
Main Authors: | Kanika Verma (Author), Shikha Makwana (Author), Sarvesh Paliwal (Author), Vartika Paliwal (Author), Smita Jain (Author), Swati Paliwal (Author), Swapnil Sharma (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic potential of reserpine in metabolic syndrome: An evidence-based study
by: Kanika Verma, et al.
Published: (2023) -
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
by: Kanika Verma, et al.
Published: (2021) -
Formulation of risperidone loaded proniosomes for effective transdermal delivery: An in-vitro and in-vivo study
by: Sharda Sambhakar, et al.
Published: (2017) -
Evaluation of anti-diabetic and antihypertensive activity of Phoenix sylvestris (L.)Roxb leaves extract and quantification of biomarker Quercetin by HPTLC
by: Pankaj Kumar Jain, et al.
Published: (2021) -
An Overview of Some Plant Based Products With Hepatoprotective Activity
by: Sonali Dnyaneshwar Labhade, et al.
Published: (2021)